FDA Week: Congress, courts concurrently tackle Allergen patent scheme
Charles Duan, senior fellow and associate director of tech & innovation policy at the R Street Institute, likewise told IHP that while there is some motivation to get the PACED Act through Congress in light of the pending litigation, he expects the court to proceed first.
Duan also noted Congress’ propensity when tackling patent issues to pass multiple patent bills together. He noted that Cotton is also a supporter of the Support Technology & Research for Our Nation’s Growth and Economic Resilience (STRONGER) Patents Act, which some supporters of the PACED Act, like AAM, are against.
